These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2987345)

  • 1. Immunoactive products of placenta. IV. Impairment by placental cells and their products of CTL function at effector stage.
    Chaouat G; Kolb JP
    J Immunol; 1985 Jul; 135(1):215-22. PubMed ID: 2987345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoactive products of placenta. III. Suppression of natural killing activity.
    Kolb JP; Chaouat G; Chassoux D
    J Immunol; 1984 May; 132(5):2305-10. PubMed ID: 6715881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine trophoblast resists cell-mediated lysis. I. Resistance to allospecific cytotoxic T lymphocytes.
    Zuckermann FA; Head JR
    J Immunol; 1987 Nov; 139(9):2856-64. PubMed ID: 3499459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoactive products of murine placenta. II.--Afferent suppression of maternal cell-mediated immunity by supernatants from short-term cultures of murine trophoblast-enriched cell suspensions.
    Chaouat G; Kolb JP
    Ann Immunol (Paris); 1984; 135C(2):205-18. PubMed ID: 6712168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
    J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
    Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T lymphocyte-mediated cytolysis. II. Role of target cell histocompatibility antigens in recognition and lysis.
    Berke G; McVey E; Hu V; Clark WR
    J Immunol; 1981 Aug; 127(2):782-7. PubMed ID: 6265557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2.
    Clark DA; Chaput A; Walker C; Rosenthal KL
    J Immunol; 1985 Mar; 134(3):1659-64. PubMed ID: 3871455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive properties of human placenta: study of supernatants from short-term syncytiotrophoblast cultures.
    Culouscou JM; Remacle-Bonnet MM; Pommier G; Rance RJ; Depieds RC
    J Reprod Immunol; 1986 Apr; 9(1):33-47. PubMed ID: 3023607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible mechanism of non-rejection of the feto-placental allograft: trophoblast resistance to lysis by cellular immune effectors.
    Zuckermann FA; Head JR
    Transplant Proc; 1987 Feb; 19(1 Pt 1):554-6. PubMed ID: 3274817
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoactive products of placenta. V: Soluble factors from murine placenta can block effector stages of maternal antipaternal cell-mediated immunity.
    Chaouat G; Kolb JP; Riviere M; Lankar D
    Am J Reprod Immunol Microbiol; 1986 Nov; 12(3):70-7. PubMed ID: 3492935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
    Good MF; Nossal GJ
    J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro.
    Berke G; Rosen D
    J Immunol; 1988 Sep; 141(5):1429-36. PubMed ID: 3261748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 3 augments the murine primary cytolytic T lymphocyte response to allogeneic tumor cells.
    Curtsinger JM; Fan DP
    J Immunol; 1984 Jul; 133(1):267-72. PubMed ID: 6427337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cytotoxic T lymphocyte and natural killer cell-mediated lysis by O,S,S,-trimethyl phosphorodithioate is at an early postrecognition step.
    Rodgers KE; Grayson MH; Ware CF
    J Immunol; 1988 Jan; 140(2):564-70. PubMed ID: 3257244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the hapten-specific T cell response. I. Preferential induction of hyporesponsiveness to the D-end of the major histocompatibility complex in the hapten-specific cytotoxic T cell response.
    Scott CF; Tsurufuji M; Benacerraf B; Sy MS
    J Immunol; 1983 Nov; 131(5):2184-9. PubMed ID: 6195256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.